252 results
Page 4 of 13
424B5
6zdrnpd5ynt70
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
avep8o7x
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
gafjfpvl7 ys
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
fpbgzo
28 Jan 21
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
9:25am
8-K
d86 of5ge4eibn452hp
28 Jan 21
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
9:25am
8-K
EX-99.1
ba2lli
22 Jan 21
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
8:32am
8-K
msmw83 nllv17i
22 Jan 21
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine Products
8:32am
8-K
EX-99.1
g69irtf6 ivbw5
20 Jan 21
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
5:06pm
8-K
kau29zx
20 Jan 21
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
5:06pm
8-K
frhm2olql
1 Dec 20
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
5:04pm
8-K
EX-99.1
piqqxnz3cr2
1 Dec 20
Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response Letter
5:04pm
8-K
EX-99.1
r551il33v3
16 Nov 20
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
5:23pm
8-K
aqjcx oiu4m3
16 Nov 20
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHI
5:23pm
8-K
EX-99.1
k8ms036nd6dtl84x
9 Nov 20
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
4:24pm
8-K
EX-99.2
u6l2fc gg2
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
y0w7tk8jt9nfvgj6n
21 Sep 20
Prospectus supplement for primary offering
6:03am
424B5
x1sskl0mdqqdpkm eix2
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
1x9ta5rg75
18 Aug 20
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update
12:00am